Starling Oncology (STLNW) Gross Margin Growth (1y) (2022 - 2026)
Analysis
Starling Oncology (STLNW) Gross Margin Growth (1y) (2022 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Davita | 11.90 Bn | 11.22 Bn | 1.16 Bn | -38.00 |
| 2 | RadNet | 5.52 Bn | 4.79 Bn | 88.08 Mn | 27.00 |
| 3 | Fresenius Medical Care AG | 4.79 Bn | 4.09 Bn | 1.52 Bn | 161.00 |
| 4 | Concentra Group Holdings Parent | 4.26 Bn | 4.10 Bn | 192.10 Mn | 238.00 |
| 5 | Privia Health | 2.57 Bn | 2.15 Bn | - | - |
| 6 | Pediatrix Medical | 2.15 Bn | 1.74 Bn | - | - |
| 7 | Progyny | 2.11 Bn | 1.87 Bn | 89.30 Mn | 175.00 |
| 8 | Surgery Partners | 1.84 Bn | 1.63 Bn | 622.10 Mn | -69.00 |
| 9 | U S Physical Therapy | 1.17 Bn | 1.15 Bn | 41.94 Mn | -150.00 |
| 10 | Starling Oncology | 4.13 Mn | -36.96 Mn | 27.17 Mn | 223.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 223.00 |
| Mar 31, 2026 | -71.00 |
| Dec 31, 2025 | -576.00 |
| Sep 30, 2025 | -53.00 |
| Jun 30, 2025 | -3,820.00 |
| Mar 31, 2025 | -3,119.00 |
| Dec 31, 2024 | 12,310.00 |
| Sep 30, 2024 | -3,081.00 |
| Jun 30, 2024 | 875.00 |
| Mar 31, 2024 | 391.00 |
| Dec 31, 2023 | -264.00 |
| Sep 30, 2023 | 79.00 |
| Jun 30, 2023 | -198.00 |
| Mar 31, 2023 | -656.00 |
| Dec 31, 2022 | -145.00 |
| Sep 30, 2022 | -703.00 |
| Jun 30, 2022 | -667.00 |
| Mar 31, 2022 | -211.00 |